The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,700.00
Ask: 1,810.00
Change: 0.00 (0.00%)
Spread: 110.00 (6.471%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 11th Mar 2013 07:23

Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling.Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral.Anite Group: Invetsec downgrades from buy to hold with a target price of 157p.Aviva: Citigroup reduces target price from 479p to 432p reiterating its buy recommendation. Bank of America shifts target price from 330p to 350p, while its neutral rating is maintained.Avocet Mining: Investec cuts target price from 28.60p to 24p and keeps a hold recommendation.Babcock: JP Morgan ups target price from 1120p to 1230p, while maintaining an overweight rating.Bovis Homes: UBS increases target price from 560p to 700p retaining a neutral rating.BP: Deutsche Bank moves target price from 500p to 520p, while leaving its buy recommendation unaltered.British American Tabacco: Investec raises target price from 3350p to 3800p reiterating a buy recommendation.Capita: Westhouse Securities takes target price from 661p to 755p, while maintaining a sell recommendation.CAP-XX: Having had both its target price and recommendation under review, Cantor Fitzgerald rates a target price of 13p and a buy recommendation.Carillion: UBS lowers target price from 240p to 230p and reiterates a sell recommendation.Chime Communications: Investec ups target price from 265p to 300p and keeps a buy recommendation.Clinigen Group: Numis revises target price from 265p to 310p and stays with its buy recommendation.Cobham: Morgan Stanley ups target price from 175p to 195p and maintains an underweight rating. Exane BNP moves target price from 205p to 230p, while staying with its neutral rating.Daily Internet: Merchant Securities initiates with a target price of 8p and a buy recommendation.Dixons Retail: Deutsche Bank shifts target price from 31p to 36p keeping a buy recommendation.Escher Group: Panmure Gordon increases target price from 384p to 410p, while maintaining a buy recommendation.GlaxoSmithKline: Deutsche Bank increases target price from 1440p to 1530p and retains a hold recommendation. Espirito Santo shifts target price from 525p to 533p, while keeping a neutral rating.Hammerson: UBS moves target price from 525p to 560p, while leaving its buy recommendation unchanged.Herencia Resources: WH Ireland downgrades from buy to a speculative buy.HG Capital Trust: Oriel Securities revises target price from 1065p to 1130p and stays with its hold recommendation.Hiscox: Westhouse Securities ups target price from 525p to 533p reiterating a neutral rating.Howden Joinery: Numis raises target price from 245p to 260p keeping an add rating.HSBC Holdings: Exane BNP cuts target price from 850p to 825p and stays with its outperform rating.Hunting: Liberum Capital raises target price from 770p to 826p, while its hold recommendation is kept.ICAP: UBS reduces target price from 330p to 305p and downgrades from neutral to sell.IMI: UBS revises target price from 1000p to 1100p, but still recommends selling.Intu Properties: Espirito Santo reduces target price from 320p to 295p keeping a sell recommendation.Ladbrokers: Panmure Gordon raises target price from 195p to 219p, while maintaining a hold recommendation. Bank of America moves target price from 235p to 260p and retains its buy recommendation.Lloyds Banking Group: Bank of America shifts target price from 65p to 70p and retains its buy recommendation.Marshalls: Citigroup moves target price from 96p to 110p staying with its neutral rating.Perform: JP Morgan raises target price from 416p to 451p and keeps its neutral rating.Petro Matad: Westhouse Securities upgrades from add to buy with a target price of 15p.Playtech: Deutsche Bank takes target price from 550p to 650p and stays with its buy recommendation.Pure Water: WH Ireland shifts target price from 8.25p to 9.75p and maintains a buy recommendation.Reckitt Benckiser: Bank of America raises target price from 5000p to 5250p and reiterates its buy recommendation.Sage: Analysts at Bank of America-Merrill Lynch have downgraded their view to underperform. Bank of America shifts target price from 320p to 330p, while downgrading to underperform.Schroders: Credit Suisse ups target price from 1800p to 2150p keeping a neutral rating.Standard Chartered: Exane BNP revises target price from 1700p to 1750op leaving its neutral rating unchanged.Standard Life: Bank of America increases target price from 340p to 375p keeping an underperform rating.SThree: Numis downgrades to hold with a target price of 350p.St Ives: Numis moves target price from 132p to 150p reiterating its buy recommendation.St Modwen Properties: Numis revises target price from 259p to 280p and downgrades to add.Tullet Prebon: UBS shifts target price from 244p to 250p, while downgrading from neutral to sell.UBM: UBS ups target price from 700p to 740p and reiterates a neutral rating. Citigroup moves target price from 734p to 749p, while its neutral rating is kept.William Hill: Bank of America takes target price from 315p to 420p and leaves its underperform rating unaltered.Wolseley: UBS raises target price from 2800p to 3375p and keeps a neutral rating.
More News
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.